Coagulation disorders of cardiopulmonary bypass: a review (Q35847687)

10 August 2017

1 reference

title

Coagulation disorders of cardiopulmonary bypass: a review (English)

1 reference

10 August 2017

1

Domenico Paparella

1 reference

10 August 2017

Stephanie J Brister

2

1 reference

PubMed ID

15278267

10 August 2017

Michael R Buchanan

series ordinal

3

1 reference

10 August 2017

24 July 2004

1 reference

10 August 2017

Intensive Care Medicine

1 reference

10 August 2017

30

1 reference

10 August 2017

10

1 reference

10 August 2017

1873-1881

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-004-2388-0

10 August 2017

0 references

cites work

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-004-2388-0

Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.

21 January 2018

1 reference

12 December 2020

Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations

1 reference

12 December 2020

Reduction of heparin dose is not beneficial to platelet function

1 reference

12 December 2020

Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.

1 reference

12 December 2020

Reoperations for bleeding after coronary artery bypass procedures during 25 years

1 reference

12 December 2020

Heparin neutralization by recombinant platelet factor 4 and protamine

1 reference

12 December 2020

Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery

1 reference

12 December 2020

Platelet function in cardiac surgery: influence of temperature and aprotinin

1 reference

12 December 2020

Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery

1 reference

12 December 2020

Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

1 reference

12 December 2020

Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.

1 reference

12 December 2020

Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy

1 reference

12 December 2020

Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction

1 reference

12 December 2020

Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2

1 reference

12 December 2020

Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass

1 reference

12 December 2020

Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?

1 reference

12 December 2020

Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass

1 reference

12 December 2020

Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass

1 reference

12 December 2020

Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation

1 reference

12 December 2020

Evaluation of tests used to monitor heparin therapy during extracorporeal circulation

1 reference

12 December 2020

Fibrinolytic response to tumor necrosis factor in healthy subjects

1 reference

12 December 2020

Fibrinolysis inhibits shear stress-induced platelet aggregation

1 reference

12 December 2020

Hypothermia-induced reversible platelet dysfunction

1 reference

12 December 2020

Role of coagulation inhibitors in inflammation

1 reference

12 December 2020

The contribution of fibrinolysis to postbypass bleeding

1 reference

12 December 2020

The coagulation-kinin pathway of human plasma

1 reference

12 December 2020

Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial

1 reference

12 December 2020

Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans

1 reference

12 December 2020

Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery

1 reference

12 December 2020

Nuclear factor kappaB mediates a procoagulant response in monocytes during extracorporeal circulation

1 reference

12 December 2020

Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints

1 reference

12 December 2020

A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.

1 reference

12 December 2020

Activated coagulation time method for control of heparin is reliable during cardiopulmonary bypass.

1 reference

12 December 2020

Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo

1 reference

12 December 2020

Heparin rebound phenomenon--much ado about nothing?

1 reference

12 December 2020

Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass

1 reference

12 December 2020

Activation of coagulation and fibrinolysis during cardiothoracic operations

1 reference

12 December 2020

Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration

1 reference

12 December 2020

RETRACTED: The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.

1 reference

12 December 2020

Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro

1 reference

12 December 2020

Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis

1 reference

12 December 2020

The effect of protamine sulfate on platelet function

1 reference

12 December 2020

Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass.

1 reference

12 December 2020

Influence of normothermic systemic perfusion during coronary artery bypass operations: a randomized prospective study

1 reference

12 December 2020

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

12 December 2020

Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?

1 reference

12 December 2020

Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood

1 reference

12 December 2020

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

1 reference

12 December 2020

Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis.

1 reference

12 December 2020

Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.

1 reference

12 December 2020

Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.

1 reference

12 December 2020

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.

1 reference

12 December 2020

Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation

1 reference

12 December 2020

Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass

1 reference

12 December 2020

Randomised trial of normothermic versus hypothermic coronary bypass surgery. The Warm Heart Investigators

1 reference

12 December 2020

Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation

1 reference

12 December 2020

Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass

1 reference

12 December 2020

Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass

1 reference

12 December 2020

Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men.

1 reference

12 December 2020

Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass

1 reference

12 December 2020

Cytokines: triggers of clinical thrombotic disease

1 reference

12 December 2020

Mechanisms of thrombin generation during surgery and cardiopulmonary bypass

1 reference

12 December 2020

The release of β- thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery

1 reference

12 December 2020

Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery

1 reference

12 December 2020

Platelet activation in warm and cold heart surgery.

1 reference

12 December 2020

Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.

1 reference

12 December 2020

The effects of heparinase 1 and protamine on platelet reactivity

1 reference

12 December 2020

Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures

1 reference

12 December 2020

Multivariate predictors of blood product use in cardiac surgery

1 reference

12 December 2020

Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principle

1 reference

12 December 2020

The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.

1 reference

12 December 2020

Effects of Extracorporeal Circulation and Heparin on the Phenotype of Platelet Surface Antigens following Heart Surgery

1 reference

12 December 2020

The platelet function defect of cardiopulmonary bypass

1 reference

12 December 2020

Factors predisposing to median sternotomy complications. Deep vs superficial infection

1 reference

12 December 2020

Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity

1 reference

12 December 2020

Tissue factor and hemostasis

1 reference

12 December 2020

Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid

1 reference

12 December 2020

Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy

1 reference

12 December 2020

Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding

1 reference

12 December 2020

Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.

1 reference

12 December 2020

Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding.

1 reference

12 December 2020

Heparin-induced platelet dysfunction and cardiopulmonary bypass

1 reference

12 December 2020

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass.

1 reference

12 December 2020

More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT

1 reference

12 December 2020

10.1007/S00134-004-2388-0

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15278267